| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0008 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |